55 Results

People

  1. Zelenetz
    Zelenetz
  2. Moskowitz
    Moskowitz
  3. Horwitz
    Horwitz
  4. Noy
    Noy
  5. Portlock
    Portlock
  6. Hamlin
    Hamlin
  7. Gerecitano
    Gerecitano
  8. Moskowitz
    Moskowitz
  9. Straus
    Straus
  10. Palomba
    Palomba

Groups

  1. Center for Hematologic Malignancies (55)
  2. Department of Medicine (55)
  3. Hematologic Malignancies, Division of (55)
  4. Lymphoma (55)
  5. Population Sciences Research Program (17)
  6. Biostatistics Service (9)
  7. Epidemiology and Biostatistics (9)
  8. Nursing (9)
  9. Radiology, Department of (7)
  10. Survivorship Research (6)
  1. "Center for Hematologic Malignancies"
  2. "Lymphoma"
  3. "2009"
Formats
  1. Meeting Abstract (27)
  2. Journal Article (25)
  3. Book Section (3)
Groups
  1. Center for Hematologic Malignancies (55)
  2. Department of Medicine (55)
  3. Hematologic Malignancies, Division of (55)
  4. Lymphoma (55)
  5. Population Sciences Research Program (17)
  6. Biostatistics Service (9)

More Groups

People
  1. Andrew Zelenetz (21)
  2. Craig Moskowitz (16)
  3. Steven Horwitz (15)
  4. Paul Hamlin (14)
  5. Ariela Noy (11)
  6. Carol Portlock (11)

More People

Years
  1. 2009 (55)
Publications
  1. Blood (21)
  2. Journal of Clinical Oncology (11)
  3. British Journal of Haematology (3)
  4. Leukemia and Lymphoma (2)
  5. The Oncologist (2)
  6. Annals of Oncology (1)

More Publications

Publishers
  1. American Society of Hematology (21)
  2. American Society of Clinical Oncology (11)
  3. John Wiley & Sons (5)
  4. Oxford University Press (3)
  5. Nature Publishing Group (2)
  6. Taylor & Francis Group (2)

More Publishers

Results (55)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Hodgkin lymphoma
    Book Section

    Yahalom, J.; Straus, D.
    In Pazdur, R.; Wagman, L. D.; Camphausen, K. A.; Hoskins, W. J. (Eds.) Cancer Management: A Multidisciplinary Approach. 12th ed (2009)

    Fulltext@MSK | Save
  • Prognostic value of quantitative image analysis (QIA) for determination of proliferative index in mantle cell lymphoma (MCL) treated with sequential chemotherapy followed by high-dose therapy and autologous stem cell rescue (HDT/ASCR)
    Meeting Abstract

    Schaffel, R.; Hedvat, C.; Teruya-Feldstein, J.; Portlock, C. S.; Moskowitz, C. H.; Zelenetz, A. D.
    Journal of Clinical Oncology (2009)

    Fulltext@MSK | Save
  • PROPEL: Results of the pivotal, multicenter, phase II study of pralatrexate in patients with relapsed or refractory peripheral T-cell lymphoma (PTCL)
    Meeting Abstract

    O'Connor, O.; Pro, B.; Pinter-Brown, L.; Popplewell, L.; Bartlett, N.; Lechowicz, M.; Savage, K.; Coiffier, B.; Saunders, M.; Horwitz, S.
    Journal of Clinical Oncology (2009)

    Fulltext@MSK | Save
  • Late mortality and morbidity of patients with Hodgkin lymphoma treated in adulthood
    Meeting Abstract

    Matasar, M. J.; McCallen, L. N.; Riedel, E. R.; Ford, J. S.; Oeffinger, K. C.; Straus, D. J.
    Journal of Clinical Oncology (2009)

    Fulltext@MSK | Save
  • First-in-human phase I study of the novel structure proteasome inhibitor NPI-0052
    Meeting Abstract

    Hamlin, P. A.; Aghajanian, C.; Younes, A.; Hong, D. S.; Palladino, M. A.; Longenecker, A. M.; Lloyd, G. K.; Hannah, A. L.; Spear, M. A.; Kurzrock, R.
    Journal of Clinical Oncology (2009)

    Fulltext@MSK | Save
  • Therapeutic and palliative benefit from single-agent irinotecan in multiply treated and highly refractory cases of lymphoma
    Meeting Abstract

    Caces, D. D.; Halaas, J.; Hamlin, P.; Noy, A.; Kewalramani, T.; Portlock, C. S.; Zelenetz, A. D.; O'Connor, O. A.; Gerecitano, J. F.
    Journal of Clinical Oncology (2009)

    Fulltext@MSK | Save
  • Clinicopathologic characteristics of HIV-associated peripheral T-cell lymphoma
    Meeting Abstract

    Castillo, J.; Beltran, B.; Collins, J.; Diez-Martin, J. L.; Hernandez-Ilizaliturri, F.; Horwitz, S. M.; Vose, J. M.
    Blood (2009)

    Fulltext@MSK | Save
  • Feasibility and toxicity of a modified dose intensive R-CODOX-M/IVAC for HIV-associated Burkitt and atypical Burkitt lymphoma (BL): Preliminary results of a prospective multicenter phase II trial of the AIDS Malignancy Consortium (AMC)
    Meeting Abstract

    Noy, A.; Kaplan, L.; Lee, J.
    Blood (2009)

    Fulltext@MSK | Save
  • Rituximab, cyclophosphamide, bortezomib and prednisone (R-CBorP): Final results of a phase I trial evaluating two dosing schedules and the safety of overlapping pegfilgrastim in patients with relapsed/refractory indolent and mantle cell lymphomas
    Meeting Abstract

    Gerecitano, J.; Portlock, C. S.; Hamlin, P. A.; Moskowitz, C. H.; Noy, A.; Straus, D. J.; Schulman, P.; Dumitrescu, O.; Sarasohn, D.; Pappanicholaou, J.; more...
    Blood (2009)

    Fulltext@MSK | Save
  • Initial remission duration of less than 1 year is no longer an adverse prognostic factor for patients with relapsed HL undergoing high dose therapy and autologous stem cell transplant: Results of a combined analysis from two large transplant centers
    Meeting Abstract

    Moskowitz, A. J.; Sweetenham, J.; Bolwell, B. J.; Maragulia, J. C.; Vanak, J. M.; Moskowitz, C. H.; Smith, S.
    Blood (2009)

    Fulltext@MSK | Save